Literature DB >> 2342668

A combination of raised serum AST:ALT ratio and erythrocyte mean cell volume level detects excessive alcohol consumption.

I Kawachi1, G M Robinson, N H Stace.   

Abstract

The usefulness of the serum aspartate aminotransferase (AST): serum alanine aminotransferase (ALT) ratio as a guide to the presence of alcoholism was evaluated in four groups of patients. In alcoholics with elevated transaminases the mean AST:ALT ratio was found to be 1.50 (95% confidence interval (CI): 1.49-1.51), in hepatitis B infection 0.51 (95% CI: 0.50-0.52), in liver cancer 1.25 (95% CI: 1.20-1.29), and in nonmalignant obstructive jaundice 0.59 (95% CI: 0.57-0.61). In alcoholics with normal transaminases the AST:ALT ratio was 1.64 (95% CI: 1.61-1.67). The combination of an AST:ALT ratio of greater than 1.00 with an erythrocyte mean cell volume (MCV) above 90.0 fL resulted in a sensitivity of 97.3% and a specificity of 88.9% for detecting alcoholism in these four groups of patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2342668

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  5 in total

Review 1.  Clinical significance in alcoholic patients of commonly encountered laboratory test results.

Authors:  G J Magarian; L M Lucas; K L Kumar
Journal:  West J Med       Date:  1992-03

2.  ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.

Authors:  Paul Y Kwo; Stanley M Cohen; Joseph K Lim
Journal:  Am J Gastroenterol       Date:  2016-12-20       Impact factor: 10.864

3.  Prevalence and risk factor analysis for the nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.

Authors:  Qiumei Zhou; Yulong Wang; Jiajia Wang; Yating Liu; Dehui Qi; Wei Yao; Hui Jiang; Tingting Li; Kaiquan Huang; Wancun Zhang; Xingxing Huo
Journal:  Medicine (Baltimore)       Date:  2021-03-12       Impact factor: 1.817

4.  Classical blood biomarkers identify patients with higher risk for relapse 6 months after alcohol withdrawal treatment.

Authors:  Florian J Raabe; Elias Wagner; Eva Hoch; Gabriele Koller; Judith Weiser; Sarah Brechtel; David Popovic; Kristina Adorjan; Oliver Pogarell
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-07-05       Impact factor: 5.270

5.  C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population.

Authors:  Amporn Atsawarungruangkit; Jirat Chenbhanich; George Dickstein
Journal:  World J Gastroenterol       Date:  2018-08-28       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.